Fess up, who is the big spender out there?
The chair issue is real, my wife sells Steelcase office furniture, the largest furniture manufacturer in the world for office environments. They are high end chairs, and come in three or more sizes to accommodate girth & weight.....guess which one is cheaper. One hospital she sells sleeper recliner chairs for a children's hospital, parents to sleep in those chairs 7 days a week staying in the room with their sick child. Guaranteed from the overweight they replace most of them on an annual basis. 225 room hospital and each has a chair at $2800 each.....$180,000 order went in last week for more sleeper chairs, and I know personally they have spent well over $1 million replacing those broken chairs in the last 7 years. An extra weight & girth normal office desk chair can cost an additional $500 over the standard size due to bigger seat, back rest, wider leg base, and stronger spring tension on the back support adjustment. Compliance to the medical handicap issues, they have to buy them for the employee.....multiply that times 5000 fat boy's that may work for a large company and that company just spent $2.5 million to accommodate obesity in the work place.
Wrong again you fool....this has support top to bottom, and the U.S. Congress will lead the way passing this bill. Repub's want business to be profitable, obesity cost business 100's of millions in lost productivity, increased health care cost, lost work time, let alone the office chair wear and tear from obese people. Those chairs aren't cheap to replace every year......hey that all goes to bottom line more profit.
Geeez, the old saying is true, "You Can't Fix Stupid". He is part of the paid fraud FUD info machine. Never Trust the Street.
$5.50 is my support target also. I think it will hold strong there. Reason's option contracts, and what they have in it, against trade volume. Shares are tight, when the price drops retail buys adding to their position. I think shorts have re-grouped around a higher option price than before. Many covered this fall, and I think it was a big effort to shake out retail that did not work entirely.
End of year profit taking. I think all the funds get together and decide to re-balance at the same time and get it over with.
Such a fool......read Sharon's post on the amendment going before congress. You have no vision other than short vision.
A few years from now, the U.S. will have taken the lead for obesity health issues around the globe......our partner knows these things will evolve. CEO's have vision to look down the road....Jack Lief did exactly that many years ago.
A very good find Ms. Sharon. After 13 years the FDA approved weight loss drugs, It was a fundamental change from the past, and they worked diligently with Arena on the entire process to meet the approval guidelines. I knew at that time that government support, not only here, but around the world was on a health movement change toward obesity. The medical obesity cost data had finally opened the eyes of officials.
I started seeing government at state levels passing legislation, obesity advocacy groups in front of congress committee hearings. A long road, but this amendment is the fruits of those labors. Excellent, the law is on our side in some manner, but work still to be done. This is bigger news for obesity that won't hit the front pages of financial news outlets. Across the isle support also.
$5.50 is the magic number, it will average around that for this week.
I predicted on Monday they would take it down into the $5.50's buy Wednesday.......boom, here it went in one trade. Strange but true. I am holding regardless, $9.02 this same date one year ago.
Cover by all means legal, and borderline illegal.......where the hell is the SEC? These unsavory trade practices have gone on for several years controlling ARNA's pps.
All things considered, the company is much further along, has a better financial position, is on the path to increasing scripts week over week, expanding coverage, expanding approval applications for other world markets. We were not in this position 1 year ago today, and the stock was trading at $9.02 on this date a year ago. My view it's worth that today, and we will see that price in the very near future again. Never have I owned a stock with such manipulation around options, and upside down positions, FUD attacks openly pound it around with misleading info, deceiving analyst (CS) reports and downgrades. Rest assured, the future is bright for ARNA, but these attacks will continue.
The management has a lot of their own skin in the game. Monthly divvie is a good yield, commercial real estate backed investment with predictable cash flow every month from the strong tenant base. Management knows what they are doing IMO. Invest on your own conclusion, I just gave you mine.
I expect they will try for $5.50 the next couple of days until they get no volume.
Market Edge present more of a short term investor horizon. I get Market Edge, Thompson-Reuters, & IQ S&P Capital, Morningstar through Scottrade. Market Edge has usually been a bit harsh on ARNA this year.